2008-006337-27: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,PARALLEL GROUP STUDY TO EVALUATE THEEFFICACY AND SAFETY OF PRX-03140 AS MONOTHERAPY INSUBJECTS WITH ALZHEIMER’S DISEASE |
|
|
| Ongoing | 2 | 75 | Europe | PRX-03140, Aricept, Aricept | EPIX Pharmaceuticals, Inc. | Alzheimer\'s Disease | | | | |